Zai Lab Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZLAB | ZYME | 1952.HK | INVA | VIR | ZBIO | |
|---|---|---|---|---|---|---|
| Market cap | 2.83B | 2.22B | 9.83B | 1.54B | 1.99B | 1.85B |
| P/E (TTM) | — | — | — | 5.0 | — | — |
| Forward P/E | -10.9 | 25.5 | 20.4 | 9.6 | -4.8 | -6.1 |
| Price/book | 4.2 | 27.5 | 1.3 | 1.4 | 2.1 | 7.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −11.45% | +66.93% | −44.53% | +14.81% | +107.78% | −7.04% |
| Today | +3.83% | +2.69% | +5.06% | +1.58% | +4.90% | +0.28% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ZLAB news ›Zai Lab Limited (ZLAB) Discusses Phase 1 Study Results of DLL3-Targeted ADC ZL-1310 in Small Cell Lung Cancer - Slideshow
2026-10-27. The following slide deck was published by Zai Lab Limited in conjunction with this event. The following slide deck was published by Zai Lab Limited in conjunction with this event. Alphabet Earnings To Accelerate The AI Bubble…
Zai Lab (NASDAQ: ZLAB) agrees to $250 million private placement financing
Posted by Defense World Staff on Oct 25th, 2026 Zai Lab Limited (NASDAQ: ZLAB) entered a securities purchase agreement for 11,340,000 American Depositary Shares in a private placement financing. Each ADS represents ten ordinary shares, and…
More from 1 other outlet
Zai Lab announces $250M private placement
Zai Lab raises $250M in PIPE financing to advance its DLL3-targeting ADC zoci. - Zai Lab (ZLAB) entered into a securities purchase agreement to sell 11.34M ADSs in a private investment in public equity (PIPE) financing at $22.04 per ADS. -…
Zai Lab’s Zoci Shows 82% Response Rate in Early Lung Cancer Study
Posted by Kim Johansen on Oct 24th, 2026 Zai Lab (NASDAQ:ZLAB) presented early-stage data at the 2026 European Society for Medical Oncology meeting for zoci, its DLL3-targeted antibody-drug conjugate, in combination with atezolizumab, with…
Zai Lab to Announce Third Quarter 2026 Financial Results and Recent Corporate Updates on November 5, 2026
BioSpace - Company to host conference call and webcast on November 5, 2026, at 8:00 a.m. ET (9:00 p.m. HKT) SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 968
Analyzing Zai Lab (NASDAQ:ZLAB) and Cytokinetics (NASDAQ:CYTK)
Cytokinetics (NASDAQ:CYTK – Get Free Report) and Zai Lab (NASDAQ:ZLAB – Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com3
- defenseworld.net2
- biospace.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.